NASDAQ: HYPDHyperion Defi Inc Stock Ownership - Who owns Hyperion Defi?
Insider buying vs selling
Have Hyperion Defi Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David R. Knox | Chief Financial Officer | 2025-12-31 | 27,950 | $3.59 | $100.34kBuy |
| Ellen R. Strahlman | Director | 2025-12-29 | 12,112 | $3.60 | $43.60kBuy |
| Ellen R. Strahlman | Director | 2025-12-29 | 11,856 | $3.61 | $42.80kBuy |
| Ellen R. Strahlman | Director | 2025-12-26 | 3,311 | $3.86 | $12.78kBuy |
| Ellen R. Strahlman | Director | 2025-12-26 | 3,601 | $3.86 | $13.91kBuy |
| Ellen R. Strahlman | Director | 2025-12-18 | 19,702 | $3.14 | $61.84kBuy |
| Ellen R. Strahlman | Director | 2025-12-18 | 18,742 | $3.14 | $58.83kBuy |
| Happy David Walters | Director | 2025-12-17 | 61,930 | $3.02 | $187.15kBuy |
| Michael S. Geltzeiler | Director | 2025-12-17 | 30,000 | $3.01 | $90.21kBuy |
HYPD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HYPD insiders and whales buy or sell their stock.
HYPD Shareholders
What type of owners hold Hyperion Defi Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stuart M. Grant | 72.00% | 10,914,153 | $42.57M | Insider |
| Shuhei Yoshida | 11.56% | 1,751,900 | $6.83M | Insider |
| Senju Pharmaceutical Co Ltd | 11.34% | 1,718,566 | $6.70M | Insider |
| Fredric N. Eshelman | 10.68% | 1,618,835 | $6.31M | Insider |
| Hyunsu Jung | 9.35% | 1,417,676 | $5.53M | Insider |
| Curt H. Labelle | 4.28% | 648,903 | $2.53M | Insider |
| Ernest Mario | 2.52% | 382,706 | $1.49M | Insider |
| David R. Knox | 2.03% | 307,119 | $1.20M | Insider |
| Morgan Stanley | 1.57% | 237,986 | $928.15k | Institution |
| Redwood Wealth Management Group LLC | 1.21% | 183,273 | $714.76k | Institution |
HYPD vs Biotech Stocks
Hyperion Defi Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.